Jump to main content

yr 〜
yr

Search results 52

Pills, power, and policy : the struggle for drug reform in Cold War America and its consequences (California/Milbank books on health and the public ; 23)

Pills, power, and policy : the struggle for drug reform in Cold War America and its consequences (California/Milbank books on health and the public ; 23)
Paper図書
Dominique A. Tobbell.University of California Press[2012]<DL533-B35>
National Diet Library

The public financing of pharmaceuticals : an economic approach / edited by Jaume Puig-Junoy.

The public financing of pharmaceuticals : an economic approach / edited by Jaume Puig-Junoy.
Paper図書
E. Elgarc2005.<DL533-B9>
National Diet Library

Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. (Princeton studies in American politics : historical, international, and comparative perspectives)

Reputation and power : organizational image and pharmaceutical regulation at the FDA / Daniel Carpenter. (Princeton studies in American politics : historical, international, and comparative perspectives)
Paper図書
Princeton University Pressc2010.<EG237-B13>
National Diet Library
  • Subject Heading...United States. Drugs -- Research -- United States. Drug Approval -- United State...

Rare Diseases Orphan Product Development Act of 2002 : report (to accompany H.R. 4014) (including cost estimate of the Congressional Budget Office) (Report)

Rare Diseases Orphan Product Development Act of 2002 : report (to accompany H.R. 4014) (including cost estimate of the Congressional Budget Office) (Report)
Microform図書
2002<YCA-Y 1.1/8:107-702>
National Diet Library

Rare Diseases Act of 2002 : report (to accompany H.R. 4013) (Report)

Rare Diseases Act of 2002 : report (to accompany H.R. 4013) (Report)
Microform図書
2002<YCA-Y 1.1/8:107-543>
National Diet Library

The truth about the drug companies : how they deceive us and what to do about it / Marcia Angell.

The truth about the drug companies : how they deceive us and what to do about it / Marcia Angell.
Paper図書
Random Housec2004.<DL533-B8>
National Diet LibraryOther Libraries in Japan

Rare Diseases Act of 2001 : report (to accompany S. 1397) (Report)

Rare Diseases Act of 2001 : report (to accompany S. 1397) (Report)
Microform図書
2001<YCA-Y 1.1/5:107-129>
National Diet Library

Pharmaceutical R&D [microform] : costs, risks, and rewards

Pharmaceutical R&D [microform] : costs, risks, and rewards
Microform図書
1993<YCA-Y 3.T 22/2:2 P 49>
National Diet Library

From test tube to patient : new drug development in the United States 2nd ed (FDA consumer special report) (DHHS publication ; no. (FDA) 95-3168)

From test tube to patient : new drug development in the United States 2nd ed (FDA consumer special report) (DHHS publication ; no. (FDA) 95-3168)
Microform図書
1995<YCA-HE 20.4010/4:D 49/995>
National Diet Library

Cancer drug research [microform] : contrary to allegation, NIH hydrazine sulfate studies were not flawed : report to the chairman and ranking minority member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight / United States General Accounting Office

Cancer drug research [microform] : contrary to allegation, NIH hydrazine sulfate studies were not flawed : report to the chairman and ranking minority member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight / United States General Accounting Office
Microform図書
1995<YCA-GA 1.13:HEHS-95-141>
National Diet Library

Orphan Drug Amendments of 1994 : report together with additional views (to accompany S. 1981) (Report)

Orphan Drug Amendments of 1994 : report together with additional views (to accompany S. 1981) (Report)
Microform図書
1994<YCA-Y 1.1/5:103-366>
National Diet Library

Legislative proposal to increase funding for medical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, first session, special hearing (S. hrg. ; 105-524)

Legislative proposal to increase funding for medical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, first session, special hearing (S. hrg. ; 105-524)
Microform図書
1998<YCA-Y 4.AP 6/2:S.HRG.105-524>
National Diet Library

Reputation and power : organizational image and pharmaceutical regulation at the FDA : pbk

Reputation and power : organizational image and pharmaceutical regulation at the FDA : pbk
Paper図書
Daniel CarpenterPrinceton University Pressc2010
Other Libraries in Japan

Structure-activity relationships of the cannabinoids / editors, Rao S. Rapaka, Alexandros Makriyannis (DHHS publication ; no. (ADM) 87-1534) (NIDA research monograph ; 79. RAUS review report)

Structure-activity relationships of the cannabinoids / editors, Rao S. Rapaka, Alexandros Makriyannis (DHHS publication ; no. (ADM) 87-1534) (NIDA research monograph ; 79. RAUS review report)
Microform図書
1987<YCA-HE 20.8216:79>
National Diet Library

National Cancer Institute investigational drug accountability record : form and instructions

National Cancer Institute investigational drug accountability record : form and instructions
Microform図書
1986<YCA-HE 20.3185:D 84>
National Diet Library

Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development : is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991

Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development : is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991
Microform図書
1992<YCA-Y 4.Sm 1:102-35>
National Diet Library

The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1992 (S. hrg. ; 103-50)

The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1992 (S. hrg. ; 103-50)
Microform図書
1993<YCA-Y 4.AG 4:S.HRG.103-50>
National Diet Library

From test tube to patient : new drug development in the United States Rev. Mar. 1990 (FDA consumer special report) (DHHS publication ; no. 90-3168)

From test tube to patient : new drug development in the United States Rev. Mar. 1990 (FDA consumer special report) (DHHS publication ; no. 90-3168)
Microform図書
1990<YCA-HE 20.4010/4:D 49/990>
National Diet Library

RU 486 : the import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990

RU 486 : the import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990
Microform図書
1991<YCA-Y 4.Sm 1:101-85>
National Diet Library

Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office) (Report)

Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office) (Report)
Microform図書
1994<YCA-Y 1.1/8:103-746>
National Diet Library
RSS